Showing results (21-30 of 286) with videos related to
Sort By:
Pageof 29
Expert Opinion on Pharmacotherapy|February 5, 2002
Insulin glargine: the first clinically useful extended-action insulin analogueS G Ashwell, P D HomeDrugs & Aging|November 1, 1993
Problems and pitfalls of sulphonylurea therapy in older patientsD A Robertson, P D HomeDiabetes Care|October 17, 1998
Optimal provision of daytime NPH insulin in patients using the insulin analog lisproA B Ahmed, P D HomeDiabetes, Obesity & Metabolism|June 21, 2013
A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetesN Freemantle, B Balkau, P D HomeDiabetic Medicine : a Journal of the British Diabetic Association|December 29, 2000
Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trialP D Home, A Lindholm, A Riis, et al.Diabetes|August 1, 1985
Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSIIP Lawson, P D Home, R BergenstalEuropean Journal of Clinical Pharmacology|June 24, 1999
Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteersP D Home, L Barriocanal, A LindholmDiabetologia|November 1, 1985
Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodiesI Hanning, P D Home, K G AlbertiBritish Heart Journal|August 1, 1992
Repeatability of measurements and sources of variability in tests of cardiovascular autonomic functionG P Lawrence, P D Home, A MurrayDiabetic Medicine : a Journal of the British Diabetic Association|January 18, 2006
Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-timesS G Ashwell, J Gebbie, P D HomePageof 29